Skip to main content
Top
Published in: Netherlands Heart Journal 9/2017

Open Access 01-09-2017 | Original Article - E‑Learning

Classical determinants of coronary artery disease as predictors of complexity of coronary lesions, assessed with the SYNTAX score

Authors: J. M. Montero-Cabezas, I. Karalis, R. Wolterbeek, A. O. Kraaijeveld, I. E. Hoefer, G. Pasterkamp, N. H. Pijls, P. A. Doevendans, J. Walterberger, J. Kuiper, A. J. van Zonneveld, J. W. Jukema

Published in: Netherlands Heart Journal | Issue 9/2017

Login to get access

Abstract

Background

We need new biomarkers that can predict cardiovascular disease to improve both diagnosis and therapeutic strategies. The CIRCULATING CELLS study was designed to study the role of several cellular mediators of atherosclerosis as biomarkers of coronary artery disease (CAD). An objective and reproducible method for the quantification of CAD extension is required to establish relationships with these potential biomarkers. We sought to analyse the correlation of the SYNTAX score with known CAD risk factors to test it as a valid marker of CAD extension.

Methods and results

A subgroup of 279 patients (67.4% males) were included in our analysis. Main exclusion criteria were a history of previous percutaneous coronary intervention or surgical revascularisation that prevent an accurate assessment of the SS. Diabetes mellitus, smoking, renal insufficiency, body mass index and a history of CAD and myocardial infarction were all positively and strongly associated with a higher SYNTAX score after adjustment for the non-modifiable biological factors (age and sex). In the multivariate model, age and male sex, along with smoking and renal insufficiency, remain statistical significantly associated with the SYNTAX score.

Conclusion

In a selected cohort of revascularisation-naive patients with CAD undergoing coronary angiography, non-modifiable cardiovascular risk factors such as advanced age, male sex, as well as smoking and renal failure were independently associated with CAD complexity assessed by the SYNTAX score. The SYNTAX score may be a valid marker of CAD extension to establish relationships with potential novel biomarkers of coronary atherosclerosis.
Literature
1.
go back to reference Hoefer IE, Sels JW, Jukema JW, et al. Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study. Clin Res Cardiol. 2013;102:847–56.CrossRefPubMed Hoefer IE, Sels JW, Jukema JW, et al. Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study. Clin Res Cardiol. 2013;102:847–56.CrossRefPubMed
2.
go back to reference Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–72.CrossRefPubMed Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–72.CrossRefPubMed
3.
go back to reference Baktir AO, Sarli B, Demirci E, et al. γ‑Glutamyl transferase activity and the burden of coronary atherosclerosis in patients with ST-segment elevation myocardial infarction. Angiology. 2014;65:812–6.CrossRefPubMed Baktir AO, Sarli B, Demirci E, et al. γ‑Glutamyl transferase activity and the burden of coronary atherosclerosis in patients with ST-segment elevation myocardial infarction. Angiology. 2014;65:812–6.CrossRefPubMed
4.
go back to reference Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.CrossRefPubMed Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.CrossRefPubMed
5.
go back to reference Tanaka T, Seto S, Yamamoto K, et al. An assessment of risk factors for the complexity of coronary artery disease using the SYNTAX score. Cardiovasc Interv Ther. 2013;28:16–21.CrossRefPubMed Tanaka T, Seto S, Yamamoto K, et al. An assessment of risk factors for the complexity of coronary artery disease using the SYNTAX score. Cardiovasc Interv Ther. 2013;28:16–21.CrossRefPubMed
6.
go back to reference Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. 2014;35:2821–30.CrossRefPubMed Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. 2014;35:2821–30.CrossRefPubMed
7.
go back to reference Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381:639–50.CrossRefPubMed Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381:639–50.CrossRefPubMed
8.
go back to reference Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.CrossRefPubMed Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.CrossRefPubMed
9.
go back to reference Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart DiseaseA Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64:1929–49.CrossRefPubMed Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart DiseaseA Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64:1929–49.CrossRefPubMed
10.
go back to reference Capodanno D, Tamburino C. Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time. Int J Cardiol. 2012;159:165–8.CrossRefPubMed Capodanno D, Tamburino C. Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time. Int J Cardiol. 2012;159:165–8.CrossRefPubMed
11.
go back to reference Claessen BE, Stone GW, Smits PC, et al. Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: a meta-analysis of a first-generation vs. a second-generation drug-eluting stent system. Neth Heart J. 2010;18:451–3.CrossRefPubMedPubMedCentral Claessen BE, Stone GW, Smits PC, et al. Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: a meta-analysis of a first-generation vs. a second-generation drug-eluting stent system. Neth Heart J. 2010;18:451–3.CrossRefPubMedPubMedCentral
12.
go back to reference Gijsberts CM, Seneviratna A, Bank IE, et al. The ethnicity-specific association of biomarkers with the angiographic severity of coronary artery disease. Neth Heart J. 2016;24:188–98.CrossRefPubMedPubMedCentral Gijsberts CM, Seneviratna A, Bank IE, et al. The ethnicity-specific association of biomarkers with the angiographic severity of coronary artery disease. Neth Heart J. 2016;24:188–98.CrossRefPubMedPubMedCentral
13.
go back to reference Yuksel IO, Cagirci G, Koklu E, et al. Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion. Neth Heart J. 2016;24:609–16.CrossRefPubMedPubMedCentral Yuksel IO, Cagirci G, Koklu E, et al. Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion. Neth Heart J. 2016;24:609–16.CrossRefPubMedPubMedCentral
14.
go back to reference Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383:999–1008.CrossRefPubMed Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383:999–1008.CrossRefPubMed
15.
go back to reference Coronary heart disease in seven countries. Summary. Circulation. 1970;41:I186–95. Coronary heart disease in seven countries. Summary. Circulation. 1970;41:I186–95.
16.
go back to reference Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–6.CrossRefPubMed Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–6.CrossRefPubMed
17.
go back to reference Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731–7.CrossRefPubMed Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731–7.CrossRefPubMed
18.
go back to reference Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108:1527–32.CrossRefPubMed Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108:1527–32.CrossRefPubMed
19.
go back to reference Labounty TM, Gomez MJ, Achenbach S, et al. Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13,874 patients. Eur Heart J Cardiovasc Imaging. 2013;14:456–63.CrossRefPubMed Labounty TM, Gomez MJ, Achenbach S, et al. Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13,874 patients. Eur Heart J Cardiovasc Imaging. 2013;14:456–63.CrossRefPubMed
20.
go back to reference Dores H, de Araújo Gonçalves P, Carvalho MS, et al. Body mass index as a predictor of the presence but not the severity of coronary artery disease evaluated by cardiac computed tomography. Eur J Prev Cardiol. 2014;21:1387–93.CrossRefPubMed Dores H, de Araújo Gonçalves P, Carvalho MS, et al. Body mass index as a predictor of the presence but not the severity of coronary artery disease evaluated by cardiac computed tomography. Eur J Prev Cardiol. 2014;21:1387–93.CrossRefPubMed
21.
go back to reference Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78.CrossRefPubMed Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78.CrossRefPubMed
22.
go back to reference Cepeda-Valery B, Chaudhry K, Slipczuk L, et al. Association between obesity and severity of coronary artery disease at the time of acute myocardial infarction: another piece of the puzzle in the ‘obesity paradox.’. Int J Cardiol. 2014;176:247–9.CrossRefPubMed Cepeda-Valery B, Chaudhry K, Slipczuk L, et al. Association between obesity and severity of coronary artery disease at the time of acute myocardial infarction: another piece of the puzzle in the ‘obesity paradox.’. Int J Cardiol. 2014;176:247–9.CrossRefPubMed
23.
go back to reference Yan L, Guo L, Zhang F, et al. The relationship between kidney function and angiographically-derived SYNTAX score. Can J Cardiol. 2011;27:768–72.CrossRefPubMed Yan L, Guo L, Zhang F, et al. The relationship between kidney function and angiographically-derived SYNTAX score. Can J Cardiol. 2011;27:768–72.CrossRefPubMed
24.
go back to reference Jukema JW, Bruschke AV, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995;91:2528–40.CrossRefPubMed Jukema JW, Bruschke AV, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995;91:2528–40.CrossRefPubMed
25.
go back to reference Hirohata A, Yamamoto K, Miyoshi T, et al. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. J Am Coll Cardiol. 2010;55:976–82.CrossRefPubMed Hirohata A, Yamamoto K, Miyoshi T, et al. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. J Am Coll Cardiol. 2010;55:976–82.CrossRefPubMed
26.
go back to reference Turfan M, Duran M, Poyraz F, et al. Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease. Coron Artery Dis. 2013;24:29–32.CrossRefPubMed Turfan M, Duran M, Poyraz F, et al. Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease. Coron Artery Dis. 2013;24:29–32.CrossRefPubMed
27.
go back to reference Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2012;63:213–7.CrossRefPubMed Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2012;63:213–7.CrossRefPubMed
28.
go back to reference Arbel Y, Zlotnik M, Halkin A, et al. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol. 2014;103:223–7.CrossRefPubMed Arbel Y, Zlotnik M, Halkin A, et al. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol. 2014;103:223–7.CrossRefPubMed
29.
go back to reference Généreux P, Palmerini T, Caixeta A, et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv. 2011;4:553–61.CrossRefPubMed Généreux P, Palmerini T, Caixeta A, et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv. 2011;4:553–61.CrossRefPubMed
Metadata
Title
Classical determinants of coronary artery disease as predictors of complexity of coronary lesions, assessed with the SYNTAX score
Authors
J. M. Montero-Cabezas
I. Karalis
R. Wolterbeek
A. O. Kraaijeveld
I. E. Hoefer
G. Pasterkamp
N. H. Pijls
P. A. Doevendans
J. Walterberger
J. Kuiper
A. J. van Zonneveld
J. W. Jukema
Publication date
01-09-2017
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 9/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-017-1005-0

Other articles of this Issue 9/2017

Netherlands Heart Journal 9/2017 Go to the issue